Pulling SEC filings + quote and writing the call…

BRIGHT HORIZONS FAMILY SOLUTIONS INC.
Next earnings Jul 29, 2026 (after close) · consensus $1.22 EPS, $790M rev
Last earnings +0.9% on 2026-05-05
Quality compounder with accelerating earnings, but 20x P/E on cyclical childcare leaves limited margin of safety at $67.90.
Revenue (FY2025) $2.93B · FY2025
Middling fundamentals offset by an attractive price (~70% below fair value) — worth a look on the value angle.
Bright Horizons is executing well across all three segments: full-service center-based childcare grew 6% with 1% net enrollment growth, back-up care surged 19% on higher utilization, and educational advisory rose 9%. The result is a clean fundamental inflection — FY2025 revenue of $2.93B (+9.2%) translated into net income of $193M (+37.8%) and diluted EPS of $3.36 (+40.0%), evidence that operating leverage is finally kicking in after the post-COVID enrollment recovery. Operating margin expanded to 10.7% and ROE reached 14.4%, while management returned cash aggressively via $225M in buybacks (up 166% YoY), shrinking the share count by 3.9%.
The balance sheet is also healthier: long-term debt fell 18.6% to $748M, current debt is zero, and cash grew 27% to $140M. Operating cash flow of $351M comfortably covers $92M in capex, leaving real free cash flow for continued buybacks and deleveraging. The 1,010-center footprint with 220+ Fortune 500 clients and multi-year employer contracts is a genuine moat — the kind of embedded B2B benefit relationship that doesn't churn easily.
Is BFAM a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.76B | $2.02B | $2.42B | $2.69B | $2.93B |
| Gross profit | $415M | $479M | $532M | $620M | $697M |
| Operating income | $129M | $158M | $171M | $247M | $315M |
| Net income | $70.5M | $80.6M | $74.2M | $140M | $193M |
| Diluted EPS | $1.15 | $1.37 | $1.28 | $2.40 | $3.36 |
| Net margin | 4.0% | 4.0% | 3.1% | 5.2% | 6.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results disclosed; routine director and say-on-pay outcomes.
New credit agreement / debt obligation entered — refinancing as long-term debt fell 19%.
Q1'26 10-Q confirms continued occupancy gains and operating leverage post-FY25.
Q1'26 earnings release; momentum from FY25 (EPS +40%, back-up care +19%) extending.
Proxy: routine director slate, exec comp and auditor ratification for 2026 meeting.
Other-events disclosure outside earnings cycle; no material financial impact flagged.
FY25 10-K: op income +28%, EPS +40%, $225M buybacks, 1,010 centers, debt down.
FY25 results: rev $2.93B (+9%), EPS $3.36 (+40%); also an officer transition disclosed.
Q3'25 10-Q: same-center occupancy improving; back-up care driving outsized growth.
Sources: SEC EDGAR (CIK 0001437578, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/25/2026, 1:25:07 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:25 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-03 | LISSY DAVID H Director | Award | 2.10K | |
| 2026-06-03 | Alleva Lawrence M Director | Award | 2.10K | |
| 2026-06-03 | Atkinson Julie Director | Award | 2.10K | |
| 2026-06-03 | HITCH JORDAN Director | Award | 2.10K | |
| 2026-06-03 | Richie Laurel Director | Award | 2.10K | |
| 2026-06-03 | Schulz Jennifer Director | Award | 2.10K | |
| 2026-06-03 | TOCIO MARY ANN Director | Award | 2.10K | |
| 2026-06-03 | BEKENSTEIN JOSHUA Director | Award | 2.10K |
| Two Sigma Investments | 1.35M sh | $111M |
| Millennium Management | 1.09M sh | $89.4M |
| Point72 Asset Management | 578K sh | $47.4M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.